| 0 (0%) | 11-11 15:55 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 10.02 | 1-year : | 11.37 |
| Resists | First : | 8.58 | Second : | 9.73 |
| Pivot price | 7.77 |
|||
| Supports | First : | 6.71 | Second : | 5.59 |
| MAs | MA(5) : | 7.64 |
MA(20) : | 7.8 |
| MA(100) : | 7.89 |
MA(250) : | 9.18 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 21.9 |
D(3) : | 27.7 |
| RSI | RSI(14): 45.2 |
|||
| 52-week | High : | 16.7 | Low : | 5.28 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ WVE ] has closed above bottom band by 31.7%. Bollinger Bands are 19.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 8.05 - 8.11 | 8.11 - 8.16 |
| Low: | 6.6 - 6.67 | 6.67 - 6.71 |
| Close: | 6.97 - 7.07 | 7.07 - 7.13 |
Tue, 11 Nov 2025
Wedbush Raises Price Target for WAVE Life Sciences (WVE) to $20 - GuruFocus
Tue, 11 Nov 2025
WVE: Wells Fargo Lowers Price Target for WAVE Life Sciences | WV - GuruFocus
Tue, 11 Nov 2025
Wave Life Sciences Ltd. (NASDAQ:WVE) Q3 2025 Earnings Call Transcript - Insider Monkey
Tue, 11 Nov 2025
Wave Life Sciences: Q3 Earnings Snapshot - theheraldreview.com
Tue, 11 Nov 2025
Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update - Investing News Network
Mon, 10 Nov 2025
Avoiding Lag: Real-Time Signals in (WVE) Movement - news.stocktradersdaily.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 159 (M) |
| Shares Float | 66 (M) |
| Held by Insiders | 15.7 (%) |
| Held by Institutions | 87.1 (%) |
| Shares Short | 13,140 (K) |
| Shares Short P.Month | 18,040 (K) |
| EPS | -0.81 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.88 |
| Profit Margin | -138.3 % |
| Operating Margin | -606.5 % |
| Return on Assets (ttm) | -39 % |
| Return on Equity (ttm) | -171.5 % |
| Qtrly Rev. Growth | -55.8 % |
| Gross Profit (p.s.) | -0.48 |
| Sales Per Share | 0.59 |
| EBITDA (p.s.) | -0.88 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -199 (M) |
| Levered Free Cash Flow | -148 (M) |
| PE Ratio | -9.22 |
| PEG Ratio | 0 |
| Price to Book value | 8.28 |
| Price to Sales | 12.49 |
| Price to Cash Flow | -5.9 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|